RXFP3/4 agonist 2
2752378-78-0
|
RXFP3 agonist 1
2752378-24-6
|
Merck SIP Agonist
635701-59-6
|
5-HT7 agonist 1
334974-31-1
|
BML 284
853220-52-7
|
NEOCARRATETRAOSE 4(1)-SULFATE SODIUM SALT
108321-78-4
|
ethyl 4-(1,3-thiazol-2-ylthiocarbamoylamino)benzoate
69123-53-1
|
2-((4-(1-METHYL-4-(PYRIDIN-4-YL)-1H-PYRAZOL-3-YL)PHENOXY)METHYL)QUINOLINE SUCCINATE
1037309-45-7
|
Cyclohexanol,4-(1,1-dimethylethyl)-1-ethynyl-
20325-03-5
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
tert-Butyl-DL-alanine
1375289-11-4
|
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
849349-65-1
|
N-[3-(Aminooxy)propyl]-N-butyl-1-butanamine
127437-46-1
|
